594 related articles for article (PubMed ID: 15498875)
1. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
Seto E; Ooka T; Middeldorp J; Takada K
Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477
[TBL] [Abstract][Full Text] [Related]
5. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
7. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
8. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
10. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
11. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.
Lai HC; Hsiao JR; Chen CW; Wu SY; Lee CH; Su IJ; Takada K; Chang Y
Virology; 2010 Sep; 405(2):464-73. PubMed ID: 20637487
[TBL] [Abstract][Full Text] [Related]
12. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
14. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
15. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
Heussinger N; Büttner M; Ott G; Brachtel E; Pilch BZ; Kremmer E; Niedobitek G
J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
[TBL] [Abstract][Full Text] [Related]
18. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
